Olympus America Inc. has expanded its medical portfolio by introducing the X-Suit NIR®, a biliary metallic stent designed with exceptional anatomic conformability and superior radial support. The X-Suit NIR’s proprietary NIRflex™ cell design provides a physician support and flexibility; both critical to help relieve the symptoms associated with pancreatic, liver and bile duct cancers.
The NIRflex™ advanced cell design biliary metallic stent provides flexible construction to fit the shape of any biliary duct. Constructed of Nitinol, the stent is water-jet cut and electro-polished for much greater durability. Each strut is also rounded, helping to reduce stress to the tissue and prevent damage to the bile duct and duodenal walls.
“Olympus provides the most extensive line of GI products and services in the industry,” said Eric Halvorson, chief marketing officer, Medical Systems Group, Olympus America, Inc. “X-Suit is a good example of how Olympus remains dedicated to expanding its offerings and working with the world’s top medical experts to provide solutions that best suit the needs of its customers and their patients.”
To ensure precise placement of the stent during a therapeutic procedure, the X-Suit NIR® has virtually no foreshortening. In addition, each end of the stent features five radiopaque markers that allow physicians to determine the position of the stent under an X-ray prior to deployment. A black marker is positioned at the proximal end of the stent facilitating endoscopic confirmation of the stent during deployment. The ease of deployment combined with superior radial support makes the X-Suit NIR® the stent of choice for re-establishing biliary flow.
Source: Lisa Koen, Golin/Harris International